Real-world survival outcomes and adverse events with adjuvant osimertinib in resected EGFR mutation-positive non-small cell lung cancer.

Authors: Vanessa Samuel, Amanda Williams Gibson, Michelle Liane Dean, Yaroslav Musiiets, Erik Nohr, Vishal Navani

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e20003

Source: Full article

---

Abstract

e20003